These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11437849)

  • 21. [Relationship between distortion product otoacoustic emissions and pure tone thresholds in normal and hearing-impaired ears].
    Chida E; Satoh N; Kawanami M; Kashiwamura M; Sakamoto T; Fukuda S; Inuyama Y
    Nihon Jibiinkoka Gakkai Kaiho; 1997 Apr; 100(4):436-43. PubMed ID: 9146016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hearing threshold estimation using concurrent measurement of distortion product otoacoustic emissions and auditory steady-state responses.
    Rosner T; Kandzia F; Oswald JA; Janssen T
    J Acoust Soc Am; 2011 Feb; 129(2):840-51. PubMed ID: 21361442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distortion-product otoacoustic emissions in humans with high frequency sensorineural hearing loss.
    Harris FP
    J Speech Hear Res; 1990 Sep; 33(3):594-600. PubMed ID: 2232776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Distortion product otoacoustic emissions in sensorineural hearing loss].
    Skotnicka B; Hassmann-Poznańska E
    Otolaryngol Pol; 1999; 53(6):693-8. PubMed ID: 10763321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transient otoacoustic emissions in children with chronic renal failure.
    Samir M; Riad H; Mahgoub M; Awad Z; Kamal N
    Clin Otolaryngol Allied Sci; 1998 Feb; 23(1):87-90. PubMed ID: 9563674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Otoacoustic emissions in early noise-induced hearing loss.
    Shupak A; Tal D; Sharoni Z; Oren M; Ravid A; Pratt H
    Otol Neurotol; 2007 Sep; 28(6):745-52. PubMed ID: 17721363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensorineural hearing loss in β-thalassemia patients treated with iron chelation.
    Osma U; Kurtoglu E; Eyigor H; Yilmaz MD; Aygener N
    Ear Nose Throat J; 2015 Dec; 94(12):481-5. PubMed ID: 26670754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaural differences of distortion product otoacoustic emission amplitudes in patients with unilateral tinnitus.
    Park JP; Lim HW; Shim BS; Kim TS; Chung JW; Yoon TH; Park HJ
    Otolaryngol Head Neck Surg; 2013 Mar; 148(3):456-9. PubMed ID: 23151834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential ototoxicity of aluminum in hemodialysis patients.
    Chu PL; Wu CC; Hsu CJ; Wang YT; Wu KD
    Laryngoscope; 2007 Jan; 117(1):137-41. PubMed ID: 17202943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Distortion product otoacoustic emissions for the assessment of auditory sensitivity].
    Chida E
    Nihon Jibiinkoka Gakkai Kaiho; 1998 Nov; 101(11):1335-47. PubMed ID: 9867000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis of sensorineural hearing loss with neural networks versus logistic regression modeling of distortion product otoacoustic emissions.
    Ziavra N; Kastanioudakis I; Trikalinos TA; Skevas A; Ioannidis JP
    Audiol Neurootol; 2004; 9(2):81-7. PubMed ID: 14981356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The relations between otoacoustic emissions and pure tone threshold].
    Chen J; Zheng Y; Li G; Meng Z
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Sep; 29(18):1591-7. PubMed ID: 26790255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The evaluation of noise-induced hearing loss with distortion product otoacoustic emissions.
    Balatsouras DG
    Med Sci Monit; 2004 May; 10(5):CR218-22. PubMed ID: 15114273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Further efforts to predict pure-tone thresholds from distortion product otoacoustic emission input/output functions.
    Gorga MP; Neely ST; Dorn PA; Hoover BM
    J Acoust Soc Am; 2003 Jun; 113(6):3275-84. PubMed ID: 12822800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evoked otoacoustic emissions--an approach for monitoring cisplatin induced ototoxicity in children.
    Stavroulaki P; Apostolopoulos N; Segas J; Tsakanikos M; Adamopoulos G
    Int J Pediatr Otorhinolaryngol; 2001 May; 59(1):47-57. PubMed ID: 11376818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of Hearing Loss Among a Representative Sample of Canadian Children and Adolescents, 3 to 19 Years of Age.
    Feder KP; Michaud D; McNamee J; Fitzpatrick E; Ramage-Morin P; Beauregard Y
    Ear Hear; 2017; 38(1):7-20. PubMed ID: 27556530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The clinical use of oto-acoustic emissions of cochlear distortion products].
    Hauser R; Probst R; Harris FP
    Laryngorhinootologie; 1991 Mar; 70(3):123-31. PubMed ID: 2036146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostics of the cochlear amplifier by means of distortion product otoacoustic emissions.
    Janssen T; Niedermeyer HP; Arnold W
    ORL J Otorhinolaryngol Relat Spec; 2006; 68(6):334-9. PubMed ID: 17065826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Study on distortion product otoacoustic emissions and expanded high frequency audiometry in noise exposure workers].
    Han J; Li F; Zhao C; Zhang Z; Ni D
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Jan; 17(1):16-9. PubMed ID: 12725180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic validity of dichotic multiple frequencies auditory steady-state responses versus distortion product otoacoustic emissions in hearing screening of high risk neonates.
    Mahmoudian S; Farhadi M; Kadivar M; Ghalehbaghi B; Rahimi F; Hemami MR; Kamrava SK; Asghari A; Amintehran E; Mohagheghi P
    Int J Pediatr Otorhinolaryngol; 2011 Sep; 75(9):1109-16. PubMed ID: 21719120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.